×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!

Development Considerations Comparing Major Markets Including US, EU, Japan and China

March 27, 2018
PAREXEL Consulting experts compare regulatory requirements in major drug development markets including the US, EU, Japan and China.
Previous Presentation
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpoints
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpoints

PAREXEL Consulting experts detail operational aspects of independent reviews in the context of immunotherap...

Next Presentation
Understanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout Commercialization

Learn how to use Real World Evidence (RWE) to bridge the evidence gap between regulators and payers.